Exhibit 107
Calculation of Filing Fee Table
Form F-1
(Form Type)
Telix Pharmaceuticals Limited
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title(1) | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price(2)(3) | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
| Fees to Be Paid | Equity | Ordinary Shares, no par value | Rule 457(o) | - | - | $ | 100,000,000.00 | 0.0001476 | $ | 14,760.00 | ||||||||||||||||
| Total Offering Amounts | $ | 100,000,000.00 | $ | 14,760.00 | ||||||||||||||||||||||
| Total Fees Previously Paid | - | |||||||||||||||||||||||||
| Total Fee Offsets | - | |||||||||||||||||||||||||
| Net Fee Due | $ | 14,760.00 | ||||||||||||||||||||||||
| (1) | All of the ordinary shares, no par value (“Ordinary Shares”), of Telix Pharmaceuticals Limited (the “Registrant”) will be represented by American Depositary Shares (“ADSs”). Each represents the right to receive Ordinary Shares. ADSs issuable upon deposit of the Ordinary Shares registered hereby are being registered under a separate registration statement on Form F-6. |
| (2) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. |
| (3) | Includes the aggregate offering price of additional Ordinary Shares represented by ADSs that the underwriters have the option to purchase solely to cover over-allotments, if any. |